Hormone Health Data and Research Act

TL;DR (AI)

• The bill directs the National Institutes of Health to evaluate evidence on hormone variability in women, particularly before perimenopause symptoms.
• It tasks the U.S. Preventive Services Task Force with reviewing the clinical utility of hormone testing for perimenopause diagnosis and management.
• The NIH and USPSTF must submit a report to Congress within 18 months, summarizing findings, identifying research gaps, and recommending future actions.